Head injury, α-synuclein genetic variability and Parkinson's disease
- PMID: 25370538
- PMCID: PMC4390403
- DOI: 10.1111/ene.12585
Head injury, α-synuclein genetic variability and Parkinson's disease
Abstract
Background and purpose: Head injury has been linked to Parkinson's disease (PD) in some but not all studies. Differences in the genetic and environmental susceptibility to PD between populations might be one explanation. The joint effects of head injuries and SNCA genetic variants were investigated.
Methods: From 2001 to 2012, 561 incident idiopathic PD cases and 721 population controls from central California were enrolled. Subjects reported on head injuries throughout their lifetime and were assessed for genetic variability in the SNCA 5' region (D4S3481; Rep1) and 3' untranslated region (rs356165). In unconditional logistic regression models adjusted for confounders, interactions between head injuries and genetic risk variants were investigated.
Results: Parkinson's disease risk in individuals with head injury who are carriers of at least one 263 bp allele in D4S3481 or rs356165 variants was 3-4.5-fold higher compared with non-carriers without head injuries. However, tests for interaction between head injury and SNCA D4S3481or rs356165 were not statistically significant.
Conclusions: Our study finds some evidence that head injury and D4S3481 or rs356165 variants jointly increase the risk of PD but little evidence of interaction.
Keywords: Parkinson's disease; gene−environment interaction; head injury.
© 2014 EAN.
Comment in
-
Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction.Eur J Neurol. 2015 Jul;22(7):e75. doi: 10.1111/ene.12694. Eur J Neurol. 2015. PMID: 26060929 No abstract available.
Similar articles
-
Head injury, α-synuclein Rep1, and Parkinson's disease.Ann Neurol. 2012 Jan;71(1):40-8. doi: 10.1002/ana.22499. Ann Neurol. 2012. PMID: 22275250 Free PMC article. Clinical Trial.
-
Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction.Eur J Neurol. 2015 Jul;22(7):e75. doi: 10.1111/ene.12694. Eur J Neurol. 2015. PMID: 26060929 No abstract available.
-
α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.PLoS One. 2012;7(5):e36199. doi: 10.1371/journal.pone.0036199. Epub 2012 May 15. PLoS One. 2012. PMID: 22615757 Free PMC article.
-
SNCA REP1 and Parkinson's disease.Neurosci Lett. 2018 Aug 24;682:79-84. doi: 10.1016/j.neulet.2018.05.043. Epub 2018 May 30. Neurosci Lett. 2018. PMID: 29859327 Review.
-
Association between alpha-synuclein (SNCA) rs11931074 variability and susceptibility to Parkinson's disease: an updated meta-analysis of 41,811 patients.Neurol Sci. 2020 Feb;41(2):271-280. doi: 10.1007/s10072-019-04107-8. Epub 2019 Nov 22. Neurol Sci. 2020. PMID: 31758346 Review.
Cited by
-
Epidemiology of mild traumatic brain injury and neurodegenerative disease.Mol Cell Neurosci. 2015 May;66(Pt B):75-80. doi: 10.1016/j.mcn.2015.03.001. Epub 2015 Mar 5. Mol Cell Neurosci. 2015. PMID: 25748121 Free PMC article. Review.
-
Novel therapies for combating chronic neuropathological sequelae of TBI.Neuropharmacology. 2019 Feb;145(Pt B):160-176. doi: 10.1016/j.neuropharm.2018.06.021. Epub 2018 Jun 20. Neuropharmacology. 2019. PMID: 29933008 Free PMC article. Review.
-
Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction.BMC Vet Res. 2020 Sep 25;16(1):356. doi: 10.1186/s12917-020-02565-3. BMC Vet Res. 2020. PMID: 32977825 Free PMC article.
-
Diesel Exhaust Extract Exposure Induces Neuronal Toxicity by Disrupting Autophagy.Toxicol Sci. 2020 Jul 1;176(1):193-202. doi: 10.1093/toxsci/kfaa055. Toxicol Sci. 2020. PMID: 32298450 Free PMC article.
-
Common SNCA Genetic Variants and Parkinson's Disease Risk: A Systematic Review and Meta-Analysis.Int J Mol Sci. 2025 Jun 23;26(13):6001. doi: 10.3390/ijms26136001. Int J Mol Sci. 2025. PMID: 40649779 Free PMC article. Review.
References
-
- Kay DM, Factor SA, Samii A, et al. Genetic association between alpha-synuclein and idiopathic Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1222–1230. - PubMed
-
- Maraganore DM, de Andrade M, Elbaz A, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006;296:661–670. - PubMed
-
- Mueller JC, Fuchs J, Hofer A, et al. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol. 2005;57:535–541. - PubMed
-
- Pals P, Lincoln S, Manning J, et al. alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol. 2004;56:591–595. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous